What Are Radiologists Doing to Prevent Contrast-Induced Nephropathy (CIN) Compared with Measures Supported by Current Evidence? A Survey of European Radiologists on CIN Associated with Computed Tomography

References

• Nash K., Hafeez A., Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930–6
   PubMed Web of Science ®Google Scholar
• Hou S. H., Bushinsky D. A., Wish J. B., Cohen J. J., Harrington J. T. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983; 74: 243–8
   PubMed Web of Science ®Google Scholar
• McCullough P. A., Wolyn R., Rocher L. L., Levin R. N., O'Neill W. W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368–75
   PubMed Web of Science ®Google Scholar
• Levy E. M., Viscoli C. M., Horwitz R. I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489–94
   PubMed Web of Science ®Google Scholar
• Solomon R. Contrast-medium-induced acute renal failure. Kidney Int 1998; 53: 230–42
   PubMed Web of Science ®Google Scholar
• Reddan D., Fishman E. K. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists. Eur J Radiol 2007, doi:10.1016/j.ejrad.2007.05.012
   PubMedGoogle Scholar
• Dodick D. W., Lipton R. B., Ferrari M. D., Goadsby P. J., McCrory D., Cutrer F. M., et al. Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project. Curr Pain Headache Rep 2004; 8: 435–42
   PubMedGoogle Scholar
• Thomsen H. S., Morcos S. K. In which patients should serum creatinine be measured before iodinated contrast medium administration?. Eur Radiol 2005; 15: 749–54
   PubMed Web of Science ®Google Scholar
• Cochran S. T. Determination of serum creatinine level prior to administration of radiographic contrast media. JAMA 1997; 277: 517–8
   PubMedGoogle Scholar
• Thomsen H. S., Morcos S. K. ESUR guidelines on contrast media. Abdom Imaging 2006; 31: 131–40
   PubMedGoogle Scholar
• Choyke P. L., Cady J., DePollar S. L., Austin H. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients?. Tech Urol 1998; 4: 65–9
   PubMedGoogle Scholar
• Tippins R. B., Torres W. E., Baumgartner B. R., Baumgarten D. A. Are screening serum creatinine levels necessary prior to outpatient CT examinations?. Radiology 2000; 216: 481–4
   PubMed Web of Science ®Google Scholar
• Olsen J. C., Salomon B. Utility of the creatinine prior to intravenous contrast studies in the emergency department. J Emerg Med 1996; 14: 543–6
   PubMedGoogle Scholar
• Bartholomew B. A., Harjai K. J., Dukkipati S., Boura J. A., Yerkey M. W., Glazier S., et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93: 1515–9
   PubMed Web of Science ®Google Scholar
• Rich M. W., Crecelius C. A. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 1990; 150: 1237–42
   PubMedGoogle Scholar
• Mehran R., Aymong E. D., Nikolsky E., Lasic Z., Iakovou I., Fahy M., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393–9
   PubMed Web of Science ®Google Scholar
• Gleeson T. G., Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol 2004; 183: 1673–89
   PubMed Web of Science ®Google Scholar
• Alamartine E., Phayphet M., Thibaudin D., Barral F. G., Veyret C. Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations. Eur J Intern Med 2003; 14: 426–31
   PubMedGoogle Scholar
• Solomon R., Werner C., Mann D., D'Elia J., Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416–20
   PubMed Web of Science ®Google Scholar
• Eisenberg R. L., Bank W. O., Hedgock M. W. Renal failure after major angiography can be avoided with hydration. Am J Roentgenol 1981; 136: 859–61
   PubMed Web of Science ®Google Scholar
• Louis B. M., Hoch B. S., Hernandez C., Namboodiri N., Neiderman G., Nissenbaum A., et al. Protection from the nephrotoxicity of contrast dye. Ren Fail 1996; 18: 639–46
   PubMed Web of Science ®Google Scholar
• Trivedi H. S., Moore H., Nasr S., Aggarwal K., Agrawal A., Goel P., et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003; 93: C29–34
   PubMed Web of Science ®Google Scholar
• Stacul F., Adam A., Becker C., Davidson C., Lameire N., McCullough P. A., et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006; 98 Suppl 1: 59–77
   Google Scholar
• Goldfarb S. Contrast-induced nephropathy: risk factors, pathophysiology, and prevention. Applied Radiology, Available at URL: http://www.ctisus.org/cta_web/8_05/AR_08_05_CTA_Goldfarb.pdf (accessed May 8, 2006)
   Google Scholar
• Mueller C., Buerkle G., Buettner H. J., Petersen J., Perruchoud A. P., Eriksson U., et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329–36
   PubMed Web of Science ®Google Scholar
• Merten G. J., Burgess W. P., Gray L. V., Holleman J. H., Roush T. S., Kowalchuk G. J., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291: 2328–34
   PubMed Web of Science ®Google Scholar
• Briguori C., Airoldi F., D'Andrea D., Bonizzoni E., Morici N., Focaccio A., et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 2007; 115: 1211–7
   PubMed Web of Science ®Google Scholar
• Recio-Mayoral A., Chaparro M., Prado B., Cózar R., Méndez I., Banerjee D., et al. The Reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol 2007; 49: 1283–8
   PubMed Web of Science ®Google Scholar
• Bader B. D., Berger E. D., Heede M. B., Silberbaur I., Duda S., Risler T., et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?. Clin Nephrol 2004; 62: 1–7
   PubMed Web of Science ®Google Scholar
• Krasuski R. A., Beard B. M., Geoghagan J. D., Thompson C. M., Guidera S. A. Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study. J Invasive Cardiol 2003; 15: 699–702
   PubMedGoogle Scholar
• Russo D., Minutolo R., Cianciaruso B., Memoli B., Conte G., De Nicola L. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 1995; 6: 1451–8
   PubMed Web of Science ®Google Scholar
• Tumlin J. A., Wang A., Murray P. T., Mathur V. S. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. Am Heart J 2002; 143: 894–903
   PubMed Web of Science ®Google Scholar
• Biondi-Zoccai G. G., Lotrionte M., Abbate A., Testa L., Remigi E., Burzotta F., et al. Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study. BMJ 2006; 332: 202–9
   PubMed Web of Science ®Google Scholar
• Goldenberg I., Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005; 172: 1461–71
   PubMed Web of Science ®Google Scholar
• Liistro F., Falsini G., Bolognese L. The clinical burden of contrast media-induced nephropathy. Ital Heart J 2003; 4: 668–76
   PubMedGoogle Scholar
• Rudnick M. R., Goldfarb S., Wexler L., Ludbrook P. A., Murphy M. J., Halpern E. F., et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995; 47: 254–61
   PubMed Web of Science ®Google Scholar
• Barrett B. J., Carlisle E. J. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993; 188: 171–8
   PubMed Web of Science ®Google Scholar
• Chalmers N., Jackson R. W. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 1999; 72: 701–3
   PubMed Web of Science ®Google Scholar
• Aspelin P., Aubry P., Fransson S. G., Strasser R., Willenbrock R., Berg K. J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491–9
   PubMed Web of Science ®Google Scholar
• Jo S. H., Youn T. J., Koo B. K., Park J. S., Kang H. J., Cho Y. S., et al. Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 2006; 48: 924–30
   PubMed Web of Science ®Google Scholar
• Sharma S. K., Kini A. Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials. Catheter Cardiovasc Interv 2005; 65: 386–93
   PubMedGoogle Scholar
• McCullough P. A., Bertrand M. E., Brinker J. A., Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared to low-osmolar contrast media. J Am Coll Cardiol 2006; 48: 692–9
   PubMed Web of Science ®Google Scholar
• Gruberg L., Mintz G. S., Mehran R., Gangas G., Lansky A. J., Kent K. M., et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542–8
   PubMed Web of Science ®Google Scholar
• Briguori C., Manganelli F., Scarpato P., Elia P. P., Golia B., Riviezzo G., et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002; 40: 298–303
   PubMed Web of Science ®Google Scholar
• Manske C. L., Sprafka J. M., Strony J. T., Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615–20
   PubMed Web of Science ®Google Scholar